Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,271,218 papers from all fields of science
Search
Sign In
Create Free Account
epirubicinol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
4'-deoxydoxorubicinol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Optimization of a liquid chromatographic separation for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites.
K. Maudens
,
C. Stove
,
W. Lambert
Journal of Separation Science
2008
Corpus ID: 28646915
The optimization of a liquid chromatographic separation of four anthracyclines (doxorubicin, epirubicin, daunorubicin and…
Expand
2004
2004
Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study
C. M. Camaggi
,
E. Strocchi
,
P. Carisi
,
A. Martoni
,
B. Melotti
,
F. Pannuti
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 3025021
In a pharmacokinetics study, six patients were treated i.v. with epirubicin (EPI) at the two dose levels of 60 and 120 mg/m2…
Expand
2004
2004
Disposition of epirubicin and metabolites with repeated courses to cancer patients
R. Morris
,
D. Kotasek
,
G. Paltridge
European Journal of Clinical Pharmacology
2004
Corpus ID: 2663982
SummaryThirteen cancer patients were studied following a total of 41 courses of epirubicin (EPI) (38–50 mg·m−2, mean 49.2 mg·m−2…
Expand
Highly Cited
2002
Highly Cited
2002
Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.
S. Fogli
,
Romano Danesi
,
Alessandra Gennari
,
Sara Donati
,
P. Conte
,
M. Tacca
Annals of Oncology
2002
Corpus ID: 14062705
BACKGROUND The objectives of this study were to investigate the disposition of gemcitabine, epirubicin, paclitaxel, 2',2…
Expand
2001
2001
Contradistinction between doxorubicin and epirubicin: in‐vivo metabolism, pharmacokinetics and toxicodynamics after single‐ and multiple‐dosing in rats
Sandhya Ramanathan‐Girish
,
M. Boroujerdi
The Journal of pharmacy and pharmacology
2001
Corpus ID: 22400902
There is compelling in‐vitro evidence that the evaluation of doxorubicin or epirubicin pharmacokinetics based solely on plasma…
Expand
Highly Cited
1999
Highly Cited
1999
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients.
M. Esposito
,
M. Venturini
,
+8 authors
R. Rosso
Journal of Clinical Oncology
1999
Corpus ID: 7461739
PURPOSE To investigate whether paclitaxel and docetaxel influence the pharmacokinetics and metabolism of epirubicin. PATIENTS…
Expand
1998
1998
Paclitaxel plus epirubicin in advanced breast cancer.
P. Conte
,
A. Gennari
,
B. Salvadori
,
C. Pazzagli
,
C. Bengala
Oncology
1998
Corpus ID: 19850709
This phase I-II study aimed to determine the maximum tolerated dose (MTD) of paclitaxel (Taxol), infused over 3 hours, when…
Expand
1996
1996
Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.
H. Dodds
,
E. Walpole
,
L. Rivory
,
R. Strong
,
S. Pond
Therapeutic Drug Monitoring
1996
Corpus ID: 25406102
Delivering emulsions of anthracycline drugs in Lipiodol, an iodinated poppy-seed oil, via the hepatic artery for the treatment of…
Expand
1990
1990
Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection.
T. Dine
,
C. Brunet
,
M. Luyckx
,
M. Cazin
,
P. Gosselin
,
J. Cazin
Biomedical chromotography
1990
Corpus ID: 22245359
A rapid sensitive and selective isocratic technique was developed for the analysis of plasma epirubicin and three of its known…
Expand
1990
1990
Jodo-Doxorubicin, ein neues Anthrazyklin-Derivat
K. Mross
,
T. Langenbuch
,
K. Burk
,
D. Hossfeld
1990
Corpus ID: 70738228
Jodo-Doxorubicin (I-DOX) gehort zu der Gruppe der Doxorubicin (DOX)-Analoge, deren erster Vertreter das bereits eingefuhrte…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required